Story perspectives

Medicare to Negotiate Drug Prices, Saving Billions by 2026

11/8/2025

43 5

Summary

Story summary

Americans pay far more for prescription drugs than their peers, with prices nearly three times higher.
Starting January 1, 2026, the Inflation Reduction Act lets Medicare negotiate prices for ten medicines, potentially saving $6 billion for Medicare and $1.5 billion for patients in year one.
Pharmaceutical companies argue linking U.S. prices to global rates could harm innovation.
Critics note high drug profits and that rebates and discounts conceal true prices.

1 of 1

Story summary

Americans pay far more for prescription drugs than their peers, with prices nearly three times higher.
Starting January 1, 2026, the Inflation Reduction Act lets Medicare negotiate prices for ten medicines, potentially saving $6 billion for Medicare and $1.5 billion for patients in year one.
Pharmaceutical companies argue linking U.S. prices to global rates could harm innovation.
Critics note high drug profits and that rebates and discounts conceal true prices.